Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
D. W. Huntjens, E. P. S. Weersink, D. L. Hilarius, N. C. Ran & E. J. F. Franssen. (2022) Severe epileptic seizures after accidental MDMA exposure in a 14-month-old child. Clinical Toxicology 60:5, pages 657-657.
Read now
Read now
Meghan L. Fletcher, Preeyaporn Sarangarm, Jacob Nash, Susan C. Smolinske, Robert L. Alunday, Steven A. Seifert & Brandon J. Warrick. (2021) A systematic review of second line therapies in toxic seizures. Clinical Toxicology 59:6, pages 451-456.
Read now
Read now
Zhan-Miao Yi, 1–3, Cheng Wen, Ting Cai, Lu Xu, Xu-Li Zhong, Si-Yan Zhan & Suo-Di Zhai. (2019) Levetiracetam for epilepsy: an evidence map of efficacy, safety and economic profiles. Neuropsychiatric Disease and Treatment 15, pages 1-19.
Read now
Read now
Michelle A. Hieger & Kevin F. Maskell. (2018) Letter in response to “Levetiracetam in toxic seizures”. Clinical Toxicology 56:3, pages 235-235.
Read now
Read now
Articles from other publishers (14)
Kevin Baumgartner, David Liss, Jason Devgun, Michael E. Mullins & Evan Schwarz. (2022) Management of Toxin-Related Seizures. Annals of Emergency Medicine 80:6, pages 572-573.
Crossref
Crossref
Zlatan Coralic, Jaideep Kapur, Kent R. Olson, James M. Chamberlain, Daniel Overbeek & Robert Silbergleit. (2022) Treatment of Toxin-Related Status Epilepticus With Levetiracetam, Fosphenytoin, or Valproate in Patients Enrolled in the Established Status Epilepticus Treatment Trial. Annals of Emergency Medicine 80:3, pages 194-202.
Crossref
Crossref
Yuele Lu, Rong Zhan, Beibei Song, Yaoyao Zhou, Linjiang Zhu, Hanchi Chen & Xiaolong Chen. (2022)
The optimized biocatalytic synthesis of (
S
)‐methyl 2‐chlorobutanoate by
Acinetobacter
sp. lipase
. Chirality 34:9, pages 1228-1238.
Crossref
Crossref
Haley N. Phillips & Laura Tormoehlen. (2022) Toxin-Induced Seizures ∗Adapted from “Toxin-Induced Seizures” in Neurologic Clinics, November 2020. Emergency Medicine Clinics of North America 40:2, pages 417-430.
Crossref
Crossref
Jou‐Yin Lai, Nicola Kalk & Emmert Roberts. (2021) The effectiveness and tolerability of anti‐seizure medication in alcohol withdrawal syndrome: a systematic review, meta‐analysis and GRADE of the evidence. Addiction 117:1, pages 5-18.
Crossref
Crossref
Sara Parreira, Ana Patrícia Antunes, Henrique Bento & Isabel Moniz. (2021) A hemlock salad: a case report of super-refractory status epilepticus after accidental hemlock ingestion. Neurological Sciences 42:10, pages 4335-4339.
Crossref
Crossref
Laura M. Tormoehlen. 2021. Emergency Neurology. Emergency Neurology
373
401
.
Kewal K. JainKewal K. Jain. 2021. Drug-induced Neurological Disorders. Drug-induced Neurological Disorders
309
323
.
Haley N. Phillips & Laura Tormoehlen. (2020) Toxin-Induced Seizures. Neurologic Clinics 38:4, pages 867-879.
Crossref
Crossref
Emily N. Dunn, Liana M. Matson, Kari M. Haines, Kimberly A. Whitten, Robyn B. Lee-Stubbs, Kyle E. Berger, Hilary S. McCarren, Cherish E. Ardinger, Cecelia E. Jackson Piercy, Stephanie M. Miller-Smith & John H. McDonough. (2020) Evaluation of fosphenytoin, levetiracetam, and propofol as treatments for nerve agent-induced seizures in pediatric and adult rats. NeuroToxicology 79, pages 58-66.
Crossref
Crossref
Vivian Lam & Robert W. Shaffer. 2020. Evidence-Based Critical Care. Evidence-Based Critical Care
63
69
.
Betul Diler Durgut, Adem Turk, Elif Acar Arslan, Tulay Kamasak, Sevim Sahin, Beril Dilber, Tugce Turkcan Soguksulu & Ali Cansu. (2019) An investigation of the ocular toxic effects of levetiracetam therapy in children with epilepsy. Child's Nervous System 35:5, pages 769-774.
Crossref
Crossref
T. M. Ostroumova, O. D. Ostroumova, E. S. Akimova & A. I. Kochetkov. (2019) Drug-induced seizures: prevalence, risk factors, treatment and prevention. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 119:11, pages 86.
Crossref
Crossref
. (2018) Multiple drugs. Reactions Weekly 1690:1, pages 138-138.
Crossref
Crossref